Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Eltromobag is an oral prescription medication classified as a thrombopoietin receptor agonist. It stimulates the bone marrow to produce more blood platelets, helping to reduce the risk of bleeding in patients with chronic immune thrombocytopenia (ITP), severe aplastic anemia, or low platelet counts related to chronic hepatitis C.
Eltromobag is an oral prescription medication classified as a thrombopoietin receptor agonist. It stimulates the bone marrow to produce more blood platelets, helping to reduce the risk of bleeding in patients with chronic immune thrombocytopenia (ITP), severe aplastic anemia, or low platelet counts related to chronic hepatitis C.